retatrutide clinical trials weight loss ESC 2024: improves lipid and cardiovascular risk profile in Phase II trial Retatrutide for weight loss: Study

My symptoms are severe

Estimated intakes via Western style diets including sweetened beverages are below 500 mg per d but, when used as a sugar replacement, intake may reach 10 to 30 g per d depending on the food consumed

The question is whether that caution is traveling far enough upstream, before patients are symptomatic

Some observational studies have suggested associations between regular consumption of artificially sweetened beverages and increased risk of type 2 diabetes, though these findings do not establish causation and may reflect confounding factors such as overall dietary patterns or reverse causality, where individuals at higher risk of diabetes choose diet beverages

Ozempic, for instance, was being used off-label quite often

Dr Johnson and coauthors explained that emerging data suggest GLP1RA may also exert anti-inflammatory effects beyond weight loss. They went on to add, As the prevalence of obesity rises in patients with [IBD], there is mounting interest in understanding the effect that GLP-1RAs have on IBD-associated outcomes. There were 580 patients with IBD (UC, n=322